Cephalon Inc. (CEPH) Inks Acquisition Deal with Sales Driven, Swiss Pharmaceutical Company Mepha AG
International biopharmaceutical company Cephalon Inc. today announced it has signed an agreement to acquire Mepha AG, a profitable, privately held, Swiss-based pharmaceutical company, as well as its subsidiaries. Mepha specializes in innovative dosage formulations and markets more than 150 products in 50 countries. In 2009, the company reported sales of approximately CHF 400 million. Mepha’s global reach has enabled it to achieve compound annual growth rates in sales of more than 13 percent over the last five years. The company also has a pipeline of about 50 chemical entities planned over the next five years. For Cephalon, Mepha’s international network…